相关实验视频

Updated: Jun 16, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

对于CAR T细胞疗法的神经损害

Meghan B Ward¹, Giedre Krenciute¹

¹Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children's Research Hospital, Memphis, TN, USA.

|June 13, 2025

概括

格拉格蒂和阿科斯塔-阿尔瓦雷斯等人. 在动物模型中研究了CAR T细胞治疗后的认知衰退. 他们的发现揭示了这些不良事件背后的机制, 这对于提高患者安全至关重要.

科学领域:

免疫学
神经科学
癌症学

背景情况:

化学抗原受体 (CAR) T细胞治疗是一种快速发展的癌症治疗方法.
包括神经毒性在内的不良事件需要进一步了解机制.
在CAR T细胞治疗后,认知能力下降是一个重大问题.

研究的目的:

研究CAR T细胞治疗后认知衰退的机制.
在各种癌症类型 (血液,固体,中枢神经系统) 中探索这些机制.
为管理与CAR T细胞相关的神经毒性提供见解.

主要方法:

使用动物模型研究CAR T细胞治疗.
在治疗后检查神经和认知功能.
分析了与不良事件有关的潜在生物途径.

主要成果:

鉴定了 CAR T 细胞管理后导致认知障碍的特定机制.
在临床前模型中证明了CAR T细胞对认知功能的影响.
描述了CAR T细胞疗法的神经生物学后果.

结论:

了解认知衰退的机制对于CAR T细胞治疗的安全性至关重要.
这些发现为缓解神经毒性提供了潜在的治疗点.
需要进一步的研究来将这些发现转化为临床实践.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.